Skip to Content

Rivastigmine Pregnancy and Breastfeeding Warnings

Rivastigmine is also known as: Exelon

Rivastigmine Pregnancy Warnings

Rivastigmine has been assigned to pregnancy category B by the FDA. Animal studies have revealed evidence of slightly decreased fetal/pup weights. There are no controlled data in human pregnancy. Rivastigmine should only be given during pregnancy when the potential benefits outweigh the potential risks.

See references

Rivastigmine Breastfeeding Warnings

Milk transfer studies in animals have not been conducted with dermal rivastigmine. In rats given rivastigmine orally, concentrations of rivastigmine plus metabolites were approximately two times higher in milk than in plasma. It is not known whether rivastigmine is excreted in human breast milk. Rivastigmine transdermal system has no indication for use in nursing mothers.

See references

References for pregnancy information

  1. "Product Information. Exelon (rivastigmine)" Novartis Pharmaceuticals, East Hanover, NJ.

References for breastfeeding information

  1. "Product Information. Exelon (rivastigmine)" Novartis Pharmaceuticals, East Hanover, NJ.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.